Alivus Life Sciences Ltd share price logo

Alivus Life Share Price

NSE: ALIVUS

BSE: 543322

Small Cap

Healthcare Sector

₹901.30

-18.50

(-2.01%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Incident Alert

Fire at Alivus Life Sciences' Dahej API plant injures three; company investigating cause and assessing damages with sufficient insurance coverage in place.

Alivus Life Stock Performance

as on February 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹895.70
    ₹918.10
    downward going graph

    0.62%

    Downside

    1.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹819.00
    ₹1,225.10
    downward going graph

    9.13%

    Downside

    35.93%

    Upside

    downward going graph

Alivus Life share price movements today

Previous Close
₹919.80
Open
₹918.10
Volume
99.70K
Upper Circuit
₹1,103.75
Lower Circuit
₹735.85
Day's Low - High
₹895.70 - ₹918.10
52 Week Low - High
₹819.00 - ₹1,225.10

Alivus Life Historical Returns

1 Month Return
+ 4.24 %
3 Month Return
-2.85 %
1 Year Return
-13.07 %
3 Year Return
+ 142.28 %
5 Year Return
+ 22.89 %

Alivus Life Fundamentals

as on February 16, 2026 at 4:01 pm IST

Market Cap

₹11,289.29 Cr

Return on Equity (ROE)

18.86

PE Ratio (TTM)

0

Return on capital employed (ROCE)

24.97

Beta (LTM)

0.82

P/B Ratio

4.7

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

9.71

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Alivus Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alivus Life with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY11,289.294.58%0.004852,386
Curis Lifesciences Ltd image
Curis Lifesciences Ltd
NA84.08-5.25%0.00649
Chandra Bhagat Pharma Ltd image
Chandra Bhagat Pharma Ltd
NA31.840.1%0.00186
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,330.98-1.9%0.7428311
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA43.1415.91%0.00433
See all

Analyst Recommendation on Alivus Life Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Alivus Life. Average target price of ₹1180

Source: S&P Global Market Intelligence

Alivus Life Share Price Target

Get share price movements and forecasts by analysts on Alivus Life.

What analysts predicted

28.29%UPSIDE

Target Price

₹1180

Current Price

₹901.3

Analyzed by

4 Analysts

High

₹1210

Target

₹1180.00

Low

₹1155

Alivus Life target price ₹1180, a slight upside of 28.29% compared to current price of ₹901.3. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Alivus Life Stock’s Investor Sentiment and Interest

Search interest for Alivus Life Sciences Ltd Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Alivus Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
621.32
578.45
595.36
572.8
536.6
588.62
506.88
641.84
649.55
601.85
587.98
672.89
Other Income
2.84
1.85
5.37
1.69
3.13
5.49
8.53
10.46
10.09
8.99
14.72
13.93
Total Income
624.16
580.3
600.73
574.5
539.73
594.11
515.41
652.3
659.63
610.83
602.7
686.82
Expenses
414.89
385.29
428.28
400.25
395.15
429.13
372.52
451.54
451.11
429.54
408.81
467.27
Operating Profit
206.43
193.16
167.08
172.55
141.45
159.49
134.36
190.3
198.44
172.31
179.17
205.62
Operating Profit Margin %
33.22%
33.39%
28.06%
30.12%
26.36%
27.1%
26.51%
29.65%
30.55%
28.63%
30.47%
30.56%
Profit Before Interest, Tax and Depreciation
209.27
195.01
172.45
174.25
144.58
164.98
142.89
200.76
208.52
181.3
193.89
219.54
Interest
0.12
0.4
0.4
0.39
0.36
0.35
0.34
0.46
1.26
1.25
1.32
1.49
Depreciation
11.52
12.61
13.13
13.18
14.53
14.39
15.09
15.16
15.97
17.06
18.44
19.66
Profit Before Tax
197.63
182
158.92
160.68
129.69
150.24
127.46
185.14
191.29
162.99
174.13
198.39
Tax Paid
51.27
46.56
40.19
41.92
31.74
38.76
32.14
48.19
49.43
41.45
44.11
48.13
Profit After Tax
146.36
135.45
118.74
118.77
97.94
111.48
95.32
136.96
141.87
121.54
130.03
150.26
Total Net profit including share of profit / Loss from associate company
146.36
135.45
118.74
118.77
97.94
111.48
95.32
136.96
141.87
121.54
130.03
150.26
EPS
11.94
11.05
9.69
9.69
7.99
9.1
7.78
11.18
11.57
9.91
10.6
12.25
Actual EPS
11.94
11.05
9.69
9.69
7.99
9.1
7.78
11.18
11.57
9.91
10.6
12.25
Adjusted EPS
11.94
11.05
9.69
9.69
7.99
9.1
7.78
11.18
11.57
9.91
10.6
12.25
Diluted EPS
11.94
11.05
9.69
9.67
7.97
9.08
7.75
11.14
11.55
9.88
10.58
12.22

Alivus Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Sales
886.42
1,537.31
1,885.17
Other Income
0.44
11.99
0.81
Total Income
886.87
1,549.3
1,885.98
Expenses
638.7
1,065.35
1,294.09
Operating Profit
247.72
471.96
591.08
Operating Profit Margin %
27.95%
30.7%
31.35%
Profit Before Interest, Tax and Depreciation
248.16
483.95
591.89
Interest
0.61
33.52
87.55
Depreciation
19.26
29.37
33.39
Profit Before Tax
228.29
421.06
470.95
Tax Paid
32.71
107.97
119.37
Profit After Tax
195.59
313.1
351.58
Total Net profit including share of profit / Loss from associate company
195.59
313.1
351.58
EPS
24.64
29.04
32.61
Actual EPS
24.64
29.04
32.61
Adjusted EPS
0.45
0.53
2.96
Diluted EPS
24.64
29.04
32.61

Alivus Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.48
10.35
195.01
388.11
597.59
306.01
413.52
391.52
Cash Flow from Investing Activities
-
-8.84
-50.52
-68.74
-122.22
-146.75
-116.48
-615.65
Cash Flow from Financing Activities
0.49
0.53
-136.55
-213.78
-78.8
-387.6
-279.45
-6.23
Net Cash Flow
0.01
2.05
7.94
105.6
396.56
-228.33
17.59
-230.35

Alivus Life Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
82.85%
82.85%
82.85%
82.85%
82.85%
82.85%
75%
75%
74.99%
74.94%
74.91%
74.91%
DII
0%
0.58%
0.64%
0.59%
1.4%
1.57%
4.16%
4.86%
5.19%
5.61%
5.47%
7.12%
FII
0%
0%
4.38%
0%
5.01%
4.82%
7.85%
6.74%
6.57%
6.42%
6.84%
5.09%
Public
13.86%
13.3%
12.12%
11.84%
10.73%
10.76%
12.98%
13.4%
13.25%
13.03%
12.78%
12.88%
Total Outstanding Shares
12,25,27,172
12,25,27,172
12,25,27,172
12,25,27,172
12,25,27,172
12,25,27,172
12,25,28,672
12,25,32,862
12,25,37,052
12,26,29,148
12,26,81,348
12,26,81,348
Total Shareholders
2,22,866
2,08,267
1,98,764
1,85,531
1,56,183
1,49,396
1,43,960
1,46,840
1,41,977
1,38,500
1,35,643
1,32,748

Mutual Funds that own Alivus Life Stock

Check out the Mutual Funds with significant holdings in Alivus Life.

Alivus Life Corporate Actions

View detailed summary of the earnings and dividend history of Alivus Life.

  • Alivus Life Sciences Ltd Earnings Results

    Alivus Life Sciences Ltd’s net profit jumped 9.71% since last year same period to ₹150.26Cr in the Q3 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 15.56% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Alivus Life Sciences Ltd Dividends May,2025

    In the quarter ending March 2025, Alivus Life Sciences Ltd has declared dividend of ₹5.00 per share on 15 May 2025 - translating a dividend yield of 0.54%.

    Read More about Dividends

Indices Featuring Alivus Life Stock

Check stock indices that include Alivus Life.

BSE Healthcare

₹42,979.96

0.80 (▲343.01%)

Insights on Alivus Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ALIVUS stock has moved up by 4.2%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 12.78% to 12.88% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.87% to 5.44% in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.91% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 170.1% return, outperforming this stock by 27.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.5% return, outperforming this stock by 45.6%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.84% to 5.09% in Dec 2025 quarter

About Alivus Life Sciences Ltd

Glenmark Life Sciences Private Limited (formerly Zorg Laboratories Private Limited) was incorporated as a private limited company on 23 June 2011. It was acquired by Glenmark Pharmaceuticals Limited in July 2018, and was converted to a public company in August 2018. Operating as a wholly-owned subsidiary of Glenmark Pharmaceuticals, the company is engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs). The company has Research and Development (R&D) facilities in Mahape, Ankleshwar, and Dahej, while its manufacturing facilities are located in Ankleshwar, Dahej, Mohol, and Kurkumbh. On 13 August 2018, Glenmark Life Sciences allotted 4,500,090 equity shares of Rs. 10 each upon conversion of a loan given to the Director, and 15,000,000 shares to its parent company Glenmark Pharmaceuticals under preferential allotment. The company recently concluded its IPO, of a total of 21,022,222 equity shares, raising Rs. 15136 million. All of the outstanding purchase consideration was repaid from the proceeds of the IPO, and the company’s equity shares are now listed on both the BSE and NSE.

Revenue: ₹672.89Cr as on December 2025 (Q3 FY26)
Net Profit: ₹150.26Cr as on December 2025 (Q3 FY26)
Listing date: 06 Aug, 2021
Chairperson Name: Glenn Saldanha
OrganisationAlivus Life Sciences Ltd
IndustryPharmaceuticals
CEOGlenn Saldanha
E-voting on sharesClick here to vote

FAQs

What is Alivus Life share price today?

Alivus Life share price today stands at ₹901.3 as on at the close of the market. Alivus Life share today touched a day high of ₹918.1 and a low of ₹895.7.

What is the 52 week high and 52 week low range for Alivus Life share?

Alivus Life touched a 52 week high of ₹1225.1 and a 52 week low of ₹819. Alivus Life share price today i.e. is closed at ₹901.3, which is -26.43% down from its 52 week high and 10.05% up from its 52 week low.

What is Alivus Life's market capitalisation today?

Alivus Life market capitalisation is ₹11,289.29 Cr as on .

How to buy Alivus Life shares?

To buy Alivus Life shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ALIVUS or Alivus Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Alivus Life shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Alivus Life trading volume today?

Alivus Life trading volume is 99.70K as on . This means that 99.70K shares of Alivus Life were bought and sold on the stock market during today's trading session.